1 completed, 1 recruiting, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow aluminum phosphate: new trials by email Literature Review of aluminum phosphate trials Research Report on aluminum phosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children OSP:rTTHc CCV 25 ㎍ with Aluminum phosphate, OSP:rTTHc CCV 25 ㎍ without Aluminum phosphate, Euvichol®-Plus - Cholera Vaccination | Phase 2 | Recruiting | International Vaccine Institute | 390 | 2026-01-13 | 2026-04-03 |
| A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years SCT1000, Gardasil®9, placebo - HPV Infection Vaccine Safety SCT1000 | Phase 1 | Unknown | Sinocelltech Ltd. | 240 | 2021-07-02 | 2021-09-17 |
| Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly Aluminum Phosphate, Placebo, EBA-175 RII-NG Malaria Vaccine - Plasmodium Falciparum Malaria | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 80 | 2006-05-01 | 2013-04-12 |
Malaria (1) · Malaria, Falciparum (1)
International Vaccine Institute (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sinocelltech Ltd. (1)
China (1) · Kenya (1) · United States (1)
Julia Lynch, MD (1)